KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Q3 2025 value amounting to $26.3 million.

  • Biomarin Pharmaceutical's Change in Inventory rose 24509.09% to $26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.1 million, marking a year-over-year increase of 5058.11%. This contributed to the annual value of $63.5 million for FY2024, which is 5955.0% down from last year.
  • Biomarin Pharmaceutical's Change in Inventory amounted to $26.3 million in Q3 2025, which was up 24509.09% from $48.1 million recorded in Q2 2025.
  • Biomarin Pharmaceutical's 5-year Change in Inventory high stood at $59.1 million for Q4 2023, and its period low was -$18.2 million during Q3 2024.
  • In the last 5 years, Biomarin Pharmaceutical's Change in Inventory had a median value of $25.5 million in 2021 and averaged $22.2 million.
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Change in Inventory tumbled by 15003.13% in 2021, and later skyrocketed by 155798.12% in 2023.
  • Quarter analysis of 5 years shows Biomarin Pharmaceutical's Change in Inventory stood at $15.9 million in 2021, then skyrocketed by 156.32% to $40.8 million in 2022, then soared by 44.72% to $59.1 million in 2023, then tumbled by 42.02% to $34.3 million in 2024, then dropped by 23.16% to $26.3 million in 2025.
  • Its Change in Inventory stands at $26.3 million for Q3 2025, versus $48.1 million for Q2 2025 and $24.3 million for Q1 2025.